GCM Grosvenor Reports Second Quarter 2023 with Private Markets Fee-Paying AUM Increasing 12% From Q2 2022 and $1.5 billion of Fundraising; Firm Increases Share Repurchase Plan to $115 million .
Form F-1 Biodexa Pharmaceuticals streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.